Literature DB >> 18809789

Common variation in the WNK1 gene and blood pressure in childhood: the Avon Longitudinal Study of Parents and Children.

Martin D Tobin1, Nicholas J Timpson, Louise V Wain, Susan Ring, Louise R Jones, Pauline M Emmett, Thomas M Palmer, Andrew R Ness, Nilesh J Samani, George Davey Smith, Paul R Burton.   

Abstract

WNK1 gene variants have been associated with adult blood pressure. We aimed to investigate relationships between WNK1 variants and blood pressure, as well as blood pressure change with age, in a longitudinal childhood study. Associations between single nucleotide polymorphisms in WNK1 and blood pressure and the rate of blood pressure change between 7 and 11 years were examined in the Avon Longitudinal Study of Parent and Children Study (n=5326 for systolic blood pressure at 11 years). We observed associations (P<0.05) with diastolic blood pressure gradient with age for 33 of 82 typed and imputed polymorphisms, including polymorphisms in exons 4, 10, and 11 (rs10774466, rs1012729, and rs9804992). The minor allele (G) of rs1012729 (frequency: 25.6%) was associated with a gender-adjusted change in a diastolic blood pressure gradient of -0.11 mm Hg/y (95% CI: -0.20 to -0.03 mm Hg/y; P=0.0054). No associations were shown with the systolic blood pressure gradient. At age 11 years, 30 polymorphisms showed association (P<0.05) with systolic blood pressure, including variants in exons 4 and 10 (rs10774466 and rs1012729). Only 3 polymorphisms were associated with diastolic blood pressure at 11 years. In exploration of polymorphism-dietary cation interactions on systolic blood pressure at 11 years, 59 reached significance (P<0.05; 12.3 expected by chance), mostly (n=33) related to dietary calcium. The findings show that common intronic and exonic WNK1 variants are associated with diastolic blood pressure gradient from 7 to 11 years and with systolic blood pressure at 11 years. Our study suggests that previously reported effects of WNK1 variants on blood pressure are mediated via effects on the gradient of blood pressure change with age.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809789     DOI: 10.1161/HYPERTENSIONAHA.108.118414

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure.

Authors:  Haifeng Tang; Yuping Zhu; Nardos Teumelsan; Shawn P Walsh; Aurash Shahripour; Birgit T Priest; Andrew M Swensen; John P Felix; Richard M Brochu; Timothy Bailey; Brande Thomas-Fowlkes; Lee-Yuh Pai; Caryn Hampton; Aaron Corona; Melba Hernandez; Joseph Metzger; Michael Forrest; Xiaoyan Zhou; Karen Owens; Vincent Tong; Emma Parmee; Sophie Roy; Gregory J Kaczorowski; Lihu Yang; Magdalena Alonso-Galicia; Maria L Garcia; Alexander Pasternak
Journal:  ACS Med Chem Lett       Date:  2016-05-12       Impact factor: 4.345

2.  Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation.

Authors:  Shawn P Walsh; Aurash Shahripour; Haifeng Tang; Nardos Teumelsan; Jessica Frie; Yuping Zhu; Birgit T Priest; Andrew M Swensen; Jessica Liu; Michael Margulis; Richard Visconti; Adam Weinglass; John P Felix; Richard M Brochu; Timothy Bailey; Brande Thomas-Fowlkes; Magdalena Alonso-Galicia; Xiaoyan Zhou; Lee-Yuh Pai; Aaron Corona; Caryn Hampton; Melba Hernandez; Ross Bentley; Jing Chen; Kashmira Shah; Joseph Metzger; Michael Forrest; Karen Owens; Vincent Tong; Sookhee Ha; Sophie Roy; Gregory J Kaczorowski; Lihu Yang; Emma Parmee; Maria L Garcia; Kathleen Sullivan; Alexander Pasternak
Journal:  ACS Med Chem Lett       Date:  2015-05-07       Impact factor: 4.345

Review 3.  Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.

Authors:  Piers R Blackett; Dharambir K Sanghera
Journal:  J Clin Lipidol       Date:  2012-04-22       Impact factor: 4.766

4.  Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.

Authors:  Haifeng Tang; Shawn P Walsh; Yan Yan; Reynalda K de Jesus; Aurash Shahripour; Nardos Teumelsan; Yuping Zhu; Sookhee Ha; Karen A Owens; Brande S Thomas-Fowlkes; John P Felix; Jessica Liu; Martin Kohler; Birgit T Priest; Timothy Bailey; Richard Brochu; Magdalena Alonso-Galicia; Gregory J Kaczorowski; Sophie Roy; Lihu Yang; Sander G Mills; Maria L Garcia; Alexander Pasternak
Journal:  ACS Med Chem Lett       Date:  2012-03-28       Impact factor: 4.345

Review 5.  The WNKs: atypical protein kinases with pleiotropic actions.

Authors:  James A McCormick; David H Ellison
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 6.  Obesity genetics and cardiometabolic health: Potential for risk prediction.

Authors:  Dharambir K Sanghera; Cynthia Bejar; Sonali Sharma; Rajeev Gupta; Piers R Blackett
Journal:  Diabetes Obes Metab       Date:  2019-03-20       Impact factor: 6.577

7.  Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans.

Authors:  Margus Putku; Katrin Kepp; Elin Org; Siim Sõber; David Comas; Margus Viigimaa; Gudrun Veldre; Peeter Juhanson; Pille Hallast; Neeme Tõnisson; Sue Shaw-Hawkins; Mark J Caulfield; Elza Khusnutdinova; Viktor Kožich; Patricia B Munroe; Maris Laan
Journal:  Hum Mutat       Date:  2011-05-10       Impact factor: 4.878

8.  Lack of family-based association between common variations in WNK1 and blood pressure level.

Authors:  Fuqiang Liu; Qiufang Lian; Jie Ren; Keyu Ren; Yang Wang; Dan Wang; Chao Chu; Lan Wang; Tongshuai Guo; Enqi Liu; Jianjun Mu; Zuyi Yuan
Journal:  Med Sci Monit       Date:  2014-10-16

9.  Polymorphisms in the WNK1 gene are associated with blood pressure variation and urinary potassium excretion.

Authors:  Stephen Newhouse; Martin Farrall; Chris Wallace; Mimoza Hoti; Beverley Burke; Philip Howard; Abiodun Onipinla; Kate Lee; Sue Shaw-Hawkins; Richard Dobson; Morris Brown; Nilesh J Samani; Anna F Dominiczak; John M Connell; G Mark Lathrop; Jaspal Kooner; John Chambers; Paul Elliott; Robert Clarke; Rory Collins; Maris Laan; Elin Org; Peeter Juhanson; Gudrun Veldre; Margus Viigimaa; Susana Eyheramendy; Francesco P Cappuccio; Chen Ji; Roberto Iacone; Pasquale Strazzullo; Meena Kumari; Michael Marmot; Eric Brunner; Mark Caulfield; Patricia B Munroe
Journal:  PLoS One       Date:  2009-04-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.